Mgen (Mycoplasma Genitalium): Why It's Becoming Harder to Treat

Introduction

Mycoplasma genitalium — commonly referred to as Mgen — is a sexually transmitted infection that has attracted increasing attention from sexual health professionals in recent years. Despite being identified in the early 1980s, it remains far less well-known than infections such as chlamydia or gonorrhoea. Yet growing rates of antibiotic resistance have made mycoplasma genitalium one of the more complex STIs for clinicians to manage.

If you have recently heard about Mgen or are experiencing mild urogenital symptoms and wondering whether they could be linked to an infection, you are not alone. Many people find themselves searching for information about unfamiliar STIs, and it is entirely reasonable to want clarity. Symptoms that may be associated with Mgen — such as mild discharge or discomfort during urination — can also be caused by a range of other conditions, including irritation, hormonal changes, or other non-sexually transmitted infections.

Our clinic provides confidential STI testing services. We do not provide GP services or dermatology consultations, but we can advise on appropriate next steps if further medical care is needed.

This article explores what mycoplasma genitalium is, why antibiotic resistance is making it increasingly difficult to treat, and when STI testing may help provide reassurance.

What Is Mycoplasma Genitalium?

Mycoplasma genitalium is one of the smallest known bacteria. It can infect the urogenital tract and is passed between partners through unprotected vaginal, anal, or — in some cases — oral sexual contact. Unlike many other bacteria, Mgen lacks a cell wall, which has significant implications for how it responds to certain classes of antibiotics.

Mycoplasma genitalium does not always cause noticeable symptoms. In many cases, individuals may carry the infection without being aware of it. When symptoms do occur, they can be mild and may overlap with symptoms caused by other conditions. This is one of the reasons Mgen can go undetected for extended periods.

> Key Summary: Mycoplasma genitalium (Mgen) is a sexually transmitted bacterial infection that often causes no obvious symptoms. When symptoms do appear, they may include mild discharge, urethral discomfort, or pelvic pain. Because these symptoms can have several possible causes — including irritation, hormonal changes, or other infections — testing may help clarify the cause, particularly following potential exposure.

Possible causes of mild urogenital symptoms may include:

• Irritation from hygiene products or clothing
• Hormonal fluctuations
• Non-sexually transmitted urinary tract infections
• Other STIs such as chlamydia or gonorrhoea
• Mycoplasma genitalium in some cases

Symptoms alone cannot confirm an STI.

When Could Urogenital Symptoms Be Linked to Mycoplasma Genitalium?

Symptoms potentially associated with Mgen may include mild urethral discharge, discomfort when urinating, or — in women — pelvic pain or bleeding between periods. These symptoms are not unique to mycoplasma genitalium and can occur with several other conditions. If symptoms develop following unprotected sexual contact or a change in sexual partner, Mgen testing may be something to consider alongside other routine screening.

It is worth noting that many individuals with confirmed Mgen infection report no symptoms whatsoever. For this reason, the decision to test is often informed by exposure history as much as by the presence of symptoms.

Common Non-STI Causes of Similar Symptoms

Before considering an STI as the cause of urogenital discomfort, it may be helpful to understand that many common, non-sexually transmitted factors can produce similar symptoms.

Irritation

Soaps, shower gels, intimate hygiene products, and even certain laundry detergents can cause localised irritation in the genital area. This can result in mild discomfort, redness, or a sensation of burning that may be mistaken for an infection.

Hormonal Changes

Hormonal fluctuations — particularly around menstruation, pregnancy, or menopause — can cause changes in vaginal discharge, dryness, or mild discomfort. These changes are often entirely physiological.

Urinary Tract Infections

Non-sexually transmitted urinary tract infections (UTIs) can cause symptoms very similar to those associated with some STIs, including pain during urination and increased urinary frequency.

Friction or Physical Irritation

Exercise, tight-fitting clothing, or sexual activity itself can sometimes cause temporary discomfort or mild inflammation that resolves without treatment.

Minor Skin Conditions

Conditions such as contact dermatitis, folliculitis, or minor skin reactions in the genital area can cause symptoms that overlap with those of certain STIs.

Situations Where Symptoms May Appear

Mild urogenital symptoms can present in a variety of everyday situations, many of which are unrelated to sexually transmitted infections:

• After sexual activity — friction or minor irritation may cause temporary discomfort
• Following exercise — sweat and movement can contribute to localised irritation
• After using new hygiene products — changes in soap or detergent may cause a reaction
• During hormonal shifts — menstrual cycle changes or contraceptive adjustments can affect discharge patterns
• After periods of stress — stress can occasionally influence urinary and reproductive symptoms

In many of these scenarios, symptoms resolve on their own without intervention.

STIs That May Cause Similar Symptoms

Several sexually transmitted infections can produce symptoms that overlap with those sometimes associated with mycoplasma genitalium. It is important to understand that no single symptom can reliably distinguish one infection from another.

Chlamydia

Chlamydia is one of the most common STIs in the UK. It can cause discharge, discomfort during urination, and — if untreated — may lead to complications. However, chlamydia frequently causes no symptoms at all. A chlamydia test can help determine whether this infection is present.

Gonorrhoea

Gonorrhoea may cause more noticeable discharge and discomfort than some other STIs, though mild or asymptomatic cases do occur. Like Mgen, gonorrhoea has also shown increasing antibiotic resistance in recent years. A gonorrhoea test may be appropriate if there is concern about exposure.

Trichomoniasis

Trichomoniasis is caused by a parasite and can produce symptoms such as discharge, itching, and discomfort. It is more commonly symptomatic in women than in men.

Herpes (HSV)

Herpes simplex virus may cause sores or ulcers in the genital area, which are distinct from the symptoms typically associated with Mgen. However, mild or atypical herpes presentations can sometimes be confused with other conditions.

It is essential to emphasise that symptoms vary considerably between individuals, and many infections — including Mgen — can cause mild or no symptoms at all.

How STI Symptoms Can Overlap With Other Conditions

One of the greatest challenges in sexual health is the degree to which symptoms of different conditions can resemble one another. Mild discharge, for example, can be associated with chlamydia, gonorrhoea, mycoplasma genitalium, a urinary tract infection, or simply a normal physiological variation.

Similarly, discomfort during urination does not reliably point to any single condition. This is precisely why symptoms alone cannot confirm infection, and laboratory-based testing remains the most reliable method for identifying the specific cause of urogenital symptoms.

Self-diagnosis based on symptoms or internet research carries a significant risk of inaccuracy. Professional testing provides a clearer picture and may help avoid unnecessary anxiety.

Why Mycoplasma Genitalium Is Becoming Harder to Treat

This is the central question — and one that concerns sexual health professionals across the UK and globally.

The Antibiotic Resistance Problem

Mycoplasma genitalium has developed resistance to several classes of antibiotics at an alarming rate. The two primary categories of antibiotics historically used to treat Mgen are macrolides (such as azithromycin) and fluoroquinolones (such as moxifloxacin).

Macrolide resistance in Mgen is now widespread. Studies suggest that in some populations, more than half of all Mgen infections carry genetic mutations that confer resistance to azithromycin. This means that a treatment course that may have been effective a decade ago could now fail to clear the infection.

Fluoroquinolone resistance is also emerging, though it remains less prevalent than macrolide resistance. Moxifloxacin is often considered a second-line treatment when azithromycin fails, but resistance to this medication is increasingly being documented.

Why Is Resistance Developing?

Several factors contribute to the growing problem of antibiotic-resistant mycoplasma genitalium:

• Empirical treatment without testing — historically, urogenital symptoms were sometimes treated with a broad-spectrum antibiotic without first confirming the specific infection. If Mgen was the underlying cause but was exposed to a sub-optimal antibiotic, resistance could develop.
• Inadequate treatment courses — incomplete courses of antibiotics or incorrect dosing can allow partially resistant bacteria to survive and multiply.
• Delayed recognition — because Mgen was not routinely tested for until relatively recently, many infections went undiagnosed, leading to prolonged exposure to inappropriate treatments.
• The biology of Mgen — the absence of a cell wall means that beta-lactam antibiotics (including penicillin and cephalosporins) are inherently ineffective against Mgen, limiting the available treatment options from the outset.

Resistance-Guided Therapy

In response to the resistance crisis, the British Association for Sexual Health and HIV (BASHH) now recommends resistance-guided therapy for Mgen. This approach involves testing specifically for mycoplasma genitalium and simultaneously checking for macrolide resistance-associated mutations before prescribing treatment.

This strategy allows clinicians to select the most appropriate antibiotic based on the resistance profile of the specific infection, improving the likelihood of successful treatment and reducing the further development of resistance.

Why Testing Matters More Than Ever

The shift towards resistance-guided therapy underscores the importance of accurate mycoplasma genitalium testing. Without knowing whether an Mgen infection carries resistance mutations, prescribing the correct treatment becomes significantly more challenging.

A full STI screen that includes mycoplasma genitalium testing can provide important information for individuals who may have been exposed to the infection.

When STI Testing May Be Sensible

Testing for mycoplasma genitalium and other STIs may be a reasonable step in several situations:

• Persistent or unexplained urogenital symptoms — particularly if they have not responded to initial treatment
• A new sexual partner — routine screening after a change in partner can provide reassurance
• Unprotected sexual contact — any instance of unprotected vaginal, anal, or oral sex carries a potential risk of STI transmission
• A partner has been diagnosed with an STI — contact tracing and testing can help prevent further transmission
• Symptoms that worsen over time — any progressive symptoms warrant investigation
• Pre-relationship screening — some individuals choose to test before entering a new sexual relationship

Testing is a personal decision. There is no obligation, but it can provide clarity and peace of mind.

How STI Testing Works

Modern STI testing is straightforward, confidential, and typically involves minimal discomfort.

Types of Tests

• Urine tests — commonly used for chlamydia, gonorrhoea, and mycoplasma genitalium. A simple urine sample is provided and sent for laboratory analysis.
• Swab tests — self-taken or clinician-taken swabs may be used depending on the site of potential exposure (urogenital, rectal, or pharyngeal).
• Blood tests — used for infections such as HIV, syphilis, and hepatitis. A syphilis test, for instance, requires a blood sample.

The Process

Samples are analysed in accredited laboratories using nucleic acid amplification tests (NAATs), which are highly sensitive and specific. Results are typically available within a few working days and are communicated confidentially.

For Mgen specifically, advanced testing can also detect macrolide resistance mutations, enabling resistance-guided therapy if treatment is needed.

When Symptoms Are Less Likely to Be an STI

It may provide reassurance to know that many common urogenital symptoms have straightforward, non-STI explanations:

• Temporary irritation following the use of a new product often resolves once the product is discontinued
• Post-exercise discomfort caused by friction or heat typically settles within a day or two
• Hormonal discharge changes around menstruation are a normal physiological process
• Minor skin reactions from shaving or waxing can cause bumps or redness that are easily mistaken for something more concerning

If there has been no recent potential exposure and symptoms are mild and self-limiting, an STI may be less likely — though testing remains the only way to confirm or exclude an infection with certainty.

Frequently Asked Questions

Can mycoplasma genitalium clear on its own?

While there is some evidence that the body may occasionally clear Mgen without treatment, this is not reliable. If Mgen is confirmed through testing, appropriate antibiotic treatment guided by resistance testing is generally recommended by healthcare professionals.

Does Mgen always cause symptoms?

No. Many individuals with mycoplasma genitalium experience no symptoms at all. Asymptomatic infection is common, which is one reason the infection can be passed on unknowingly.

Should I test for Mgen if my symptoms have disappeared?

In some cases, symptoms may resolve temporarily even though an infection remains present. If there has been potential exposure, testing may still be worthwhile regardless of whether symptoms are currently present.

How soon after exposure should I test for Mgen?

Nucleic acid amplification tests for mycoplasma genitalium are generally considered reliable from approximately two weeks after potential exposure, though specific guidance may vary.

Is mycoplasma genitalium more common than chlamydia?

Mgen is less prevalent than chlamydia in most UK populations, though it is not rare. The exact prevalence is difficult to determine because routine screening for Mgen is not yet as widespread as for chlamydia and gonorrhoea.

Can condoms prevent Mgen transmission?

Consistent and correct use of condoms significantly reduces the risk of Mgen transmission, as with most sexually transmitted infections. However, no barrier method provides absolute protection.

When to Seek Medical Advice

While many urogenital symptoms have benign explanations, there are situations where seeking medical advice promptly is important:

• Severe or worsening pain in the pelvic or genital area
• Ulcers, sores, or blisters that develop in the genital region
• Fever or systemic symptoms alongside urogenital complaints
• Persistent symptoms that do not improve over several days
• Unusual or heavy discharge that is markedly different from normal
• Pain during sexual intercourse that is new or progressive

If symptoms persist or worsen, consultation with an appropriate healthcare service may be advised. Early assessment can help identify the cause and ensure appropriate management.

Confidential STI Testing in the UK

If you are concerned about possible STI symptoms or exposure — including concerns about mycoplasma genitalium — confidential STI testing appointments are available at our UK clinic. Testing decisions depend on symptoms, exposure history, and individual risk factors.

Our clinic provides private STI testing, including targeted Mgen testing with macrolide resistance marker detection. Whether you are experiencing symptoms or simply wish to confirm your status after a potential exposure, our team can advise on the most appropriate testing pathway for your circumstances.

Please contact us for current pricing and availability; a full breakdown of costs will be provided before any testing is undertaken. Testing recommendations and treatment suitability depend on individual clinical assessment. Please consult an appropriate healthcare professional for personalised medical advice.

Regulatory & Compliance

This content has been produced in accordance with the following UK regulatory and advertising standards:

• ASA (Advertising Standards Authority): All content complies with the ASA CAP Code, ensuring that claims are accurate, substantiated, and not misleading. No guarantees of outcomes are made.
• CQC (Care Quality Commission): Our clinic operates in accordance with CQC fundamental standards of quality and safety.
• GMC (General Medical Council): All clinical services operate under appropriate medical governance, and content has been reviewed to ensure alignment with GMC Good Medical Practice standards.
• NMC (Nursing & Midwifery Council): Our nurse-led clinic adheres to NMC standards for professional practice, and all content aligns with guidance on providing accurate, evidence-based health information.

Disclaimer: This article is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. The information provided is not a substitute for professional clinical judgement. Sexual health concerns should be assessed on an individual basis by a qualified healthcare professional. If you are experiencing persistent, severe, or worsening symptoms, please consult an appropriate healthcare service. Our clinic provides private STI testing services only — we do not prescribe medication, provide ongoing treatment, or offer GP services.

Written: 27 March 2026 | Next Review Due: 27 March 2027